401 related articles for article (PubMed ID: 30668314)
21. Tamoxifen and raloxifene suppress the proliferation of estrogen receptor-negative cells through inhibition of glutamine uptake.
Todorova VK; Kaufmann Y; Luo S; Klimberg VS
Cancer Chemother Pharmacol; 2011 Feb; 67(2):285-91. PubMed ID: 20383709
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of Glutamine Uptake Improves the Efficacy of Cetuximab on Gastric Cancer.
Ma H; Wu J; Zhou M; Wu J; Wu Z; Lin L; Huang N; Liao W; Sun L
Integr Cancer Ther; 2021; 20():15347354211045349. PubMed ID: 34590499
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of the ʟ-glutamine transporter ASCT2 sensitizes plasma cell myeloma cells to proteasome inhibitors.
Prelowska MK; Mehlich D; Ugurlu MT; Kedzierska H; Cwiek A; Kosnik A; Kaminska K; Marusiak AA; Nowis D
Cancer Lett; 2021 Jun; 507():13-25. PubMed ID: 33713737
[TBL] [Abstract][Full Text] [Related]
24. LncRNA
Jiang J; Dong W; Zhang W; Wang Q; Wang R; Wang J; Wu H; Dong H; Zhao RC; Wang J; Li Z
Discov Med; 2023 Dec; 35(179):995-1014. PubMed ID: 38058065
[TBL] [Abstract][Full Text] [Related]
25. Inducible antisense RNA targeting amino acid transporter ATB0/ASCT2 elicits apoptosis in human hepatoma cells.
Fuchs BC; Perez JC; Suetterlin JE; Chaudhry SB; Bode BP
Am J Physiol Gastrointest Liver Physiol; 2004 Mar; 286(3):G467-78. PubMed ID: 14563674
[TBL] [Abstract][Full Text] [Related]
26. NEDD4L downregulates autophagy and cell growth by modulating ULK1 and a glutamine transporter.
Lee DE; Yoo JE; Kim J; Kim S; Kim S; Lee H; Cheong H
Cell Death Dis; 2020 Jan; 11(1):38. PubMed ID: 31959741
[TBL] [Abstract][Full Text] [Related]
27. Clinical Role of ASCT2 (SLC1A5) in KRAS-Mutated Colorectal Cancer.
Toda K; Nishikawa G; Iwamoto M; Itatani Y; Takahashi R; Sakai Y; Kawada K
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28749408
[TBL] [Abstract][Full Text] [Related]
28. NDRG2 ablation reprograms metastatic cancer cells towards glutamine dependence
Ding M; Bu X; Li Z; Xu H; Feng L; Hu J; Wei X; Gao J; Tao Y; Cai B; Liu Y; Qu X; Shen L
Int J Biol Sci; 2020; 16(16):3100-3115. PubMed ID: 33162818
[No Abstract] [Full Text] [Related]
29. Neddylation inhibition induces glutamine uptake and metabolism by targeting CRL3
Zhou Q; Lin W; Wang C; Sun F; Ju S; Chen Q; Wang Y; Chen Y; Li H; Wang L; Hu Z; Jin H; Wang X; Sun Y
Nat Commun; 2022 May; 13(1):3034. PubMed ID: 35641493
[TBL] [Abstract][Full Text] [Related]
30. Molecular identification and characterisation of the glycine transporter (GLYT1) and the glutamine/glutamate transporter (ASCT2) in the rat lens.
Lim J; Lorentzen KA; Kistler J; Donaldson PJ
Exp Eye Res; 2006 Aug; 83(2):447-55. PubMed ID: 16635486
[TBL] [Abstract][Full Text] [Related]
31. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of glucose metabolism prevents glycosylation of the glutamine transporter ASCT2 and promotes compensatory LAT1 upregulation in leukemia cells.
Polet F; Martherus R; Corbet C; Pinto A; Feron O
Oncotarget; 2016 Jul; 7(29):46371-46383. PubMed ID: 27344174
[TBL] [Abstract][Full Text] [Related]
33. Sorting nexin 27 (SNX27) regulates the trafficking and activity of the glutamine transporter ASCT2.
Yang Z; Follett J; Kerr MC; Clairfeuille T; Chandra M; Collins BM; Teasdale RD
J Biol Chem; 2018 May; 293(18):6802-6811. PubMed ID: 29563155
[TBL] [Abstract][Full Text] [Related]
34. The role of the glutamine transporter ASCT2 in antineoplastic therapy.
Teixeira E; Silva C; Martel F
Cancer Chemother Pharmacol; 2021 Apr; 87(4):447-464. PubMed ID: 33464409
[TBL] [Abstract][Full Text] [Related]
35. A Variant of SLC1A5 Is a Mitochondrial Glutamine Transporter for Metabolic Reprogramming in Cancer Cells.
Yoo HC; Park SJ; Nam M; Kang J; Kim K; Yeo JH; Kim JK; Heo Y; Lee HS; Lee MY; Lee CW; Kang JS; Kim YH; Lee J; Choi J; Hwang GS; Bang S; Han JM
Cell Metab; 2020 Feb; 31(2):267-283.e12. PubMed ID: 31866442
[TBL] [Abstract][Full Text] [Related]
36. NG as a novel nitric oxide donor induces apoptosis by increasing reactive oxygen species and inhibiting mitochondrial function in MGC803 cells.
Liu L; Li T; Tan J; Fu J; Guo Q; Ji H; Zhang Y
Int Immunopharmacol; 2014 Nov; 23(1):27-36. PubMed ID: 25135879
[TBL] [Abstract][Full Text] [Related]
37. Clinical associations between ASCT2 and p‑mTOR in the pathogenesis and prognosis of epithelial ovarian cancer.
Guo H; Xu Y; Wang F; Shen Z; Tuo X; Qian H; Wang H; Wang K
Oncol Rep; 2018 Dec; 40(6):3725-3733. PubMed ID: 30272366
[TBL] [Abstract][Full Text] [Related]
38. Synergistic combination of DT-13 and Topotecan inhibits aerobic glycolysis in human gastric carcinoma BGC-823 cells via NM IIA/EGFR/HK II axis.
Yu XW; Wei D; Gao YS; Du HZ; Yu BY; Li RM; Qian CM; Luo XJ; Yuan ST; Wang JS; Sun L
J Cell Mol Med; 2019 Oct; 23(10):6622-6634. PubMed ID: 31397978
[TBL] [Abstract][Full Text] [Related]
39. Cinobufagin Induces Apoptosis in Osteosarcoma Cells Via the Mitochondria-Mediated Apoptotic Pathway.
Dai G; Zheng D; Guo W; Yang J; Cheng AY
Cell Physiol Biochem; 2018; 46(3):1134-1147. PubMed ID: 29669353
[TBL] [Abstract][Full Text] [Related]
40. Glutamine addiction activates polyglutamine-based nanocarriers delivering therapeutic siRNAs to orthotopic lung tumor mediated by glutamine transporter SLC1A5.
Wang C; Wu J; Wang Z; Yang Z; Li Z; Deng H; Li L; Peng X; Feng M
Biomaterials; 2018 Nov; 183():77-92. PubMed ID: 30149232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]